Primary Record
Eletriptan
Note: Only for scientific research or as raw materials for production.
- In stock
- 8,793 g
- Purity
- 98.9 %
- CAS
- 143322-58-1
Compound Identifiers & Properties
- CAS
- 143322-58-1
- PubChem CID
- 77993
- SMILES
- CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
- Canonical SMILES
- CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12
Names & Synonyms
- Eletriptan
- Relpax
- eletriptanum
- 143322-58-1
- Eletriptan HBr
- Eletriptan (INN)
- Eletriptan [INN:BAN]
- Relpax (TN)
- Eletriptan Free Base
- Eletriptan hydrobromide
- 22QOO9B8KI
- ELETRIPTAN [MI]
- RefChem:57394
- UNII-22QOO9B8KI
- ELETRIPTAN [INN]
- DTXSID9046861
- ELETRIPTAN [VANDF]
- CHEBI:50922
- D02DMQ
- GTPL40
- UK 116044
- CHEMBL1510
- ELETRIPTAN [WHO-DD]
- SCHEMBL26719
- DTXCID7026861
- UK-116044
- PWVXXGRKLHYWKM-LJQANCHMSA-N
- AC1L2U98
- orb1710738
- SCHEMBL29414096
- UK-116,044
- C22H26N2O2S
- CTK8F9426
- KS-00000XLD
- UK-116044-04 FREE BASE
- N02CC06
- MFCD00943792
- UK-116,044-04 FREE BASE
- CID77993
- HY-A0039
- ZINC3823475
- Tox21_112737
- BDBM50103594
- C22-H26-N2-O2-S
- EBC-26873
- NCGC00181130-01
- AKOS005145842
- AKOS015851019
- Tox21_112737_1
- AC-3397
- ACN-046382
- AM84392
- AN-5266
- DB00216
- UK-116044-04 [As Hydrobromide)
- UK-116,044-04 [as hydrobromide]
- UK-116044-04
- NCGC00181130-02
- NCGC00181130-04
- NCGC00181130-06
- AJ-45734
- BC220499
- UK116044
- AB1004885
- J979.643F
- LS-186998
- LS-187637
- UK 166044
- UK-166044
- 2568B
- CAS-143322-58-1
- CS-0006741
- FT-0631166
- NS00002572
- UK-166,044
- 5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole
- D07887
- UK 116044-04
- (R)-3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole
- 5-[2-(benzenesulfonyl)ethyl]-3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-1H-indole
- 834E923
- A808057
- EN300-25323635
- Q415032
- 3-(((R)-1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)indole
- 3-[[(2r)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1h-indole
- 1H-Indole, 3-(((2R)-1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)ethyl)-
- BRD-K30652337-001-01-9
- BRD-K30652337-004-01-3
- BRD-K30652337-004-02-1
- (R)-5-[2-(Benzenesulfonyl)ethyl]-3-[(N-methylpyrrolidin-2-yl)methyl]-1H-indole
- 3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1H-indole
- 177834-92-3
- (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole
- (R)-5-(2-Phenylsulfonylethyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole
- 3-(N-methyl-2(R)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethyl)-1H-indole
- (R)-3-[(1-Methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-Indole
- (R)-5-(2-benzenesulphonylethyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole
- (S)-3-((1-Methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole
- 1h-indol, 3-[[(2r)-1-metil-2-pirrolidinil]metil]-5-[2-(fenilsulfonil)etil]-
- 1H-Indole 3-[(1-methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-(R)-
- 1H-Indole, 3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-
- 3-(((2R)-1-methylpyrrolidin-2-yl)methyl)-5-(2-phenylsulfonylethyl)-1H-indole
- 3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-5-(2-phenylsulfonylethyl)-1H-indole
- 3-[[(2R)-1-Methylpyrrolidine-2-yl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole
- 3-{[1-methylpyrrolidin-2(R)-yl]methyl}-5-(2-phenylsulphonylethyl)-1H-indole
- 5-(2-(benzenesulfonyl)ethyl)-3-(((2R)-1-methylpyrrolidin-2-yl)methyl)-1H-indole
- 5-[2-(benzenesulfonyl)ethyl]-3-(1-methylpyrrolidin-2(R)-ylmethyl)-1H-indole
- (R)-3-[(1-Methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-Indole; (R)-5-[2-(Benzenesulfonyl)ethyl]-3-[(N-methylpyrrolidin-2-yl)methyl]-1H-indole; Eletriptan
- 3-[[(2R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole; 1H-Indole, 3-[(1-methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-, (R)-; (R)-5-[2-(Benzenesulfonyl)ethyl]-3-[(N-methylpyrrolidin-2-yl)methyl]-1H-indole; Eletriptan; UK 116044